M yeloneuropathy resulting from copper deficiency is an increasingly recognized cause of gait unsteadiness. 1 Established causes of copper deficiency include excessive zinc or iron ingestion, history of prior gastric surgery, malabsorption, nephrotic syndrome, and enteral nutrition without adequate copper replacement. In the largest series to date, a cause of copper deficiency could not be established in over one-third of 25 reported cases of copper deficiency myelopathy. 2 This case report details the development of copper deficiency myeloneuropathy in a patient who ultimately was diagnosed with celiac disease, despite having no overt gastrointestinal symptoms.
CASE REPORT
A 69-year-old woman was evaluated for a 5-year history of progressive gait unsteadiness and paresthesias involving the distal lower extremities. Her medical history was significant only for osteoporosis and unexplained weight loss over the previous few years before evaluation. She did not take excessive amounts of zinc, had no history of gastric surgery, and denied any gastrointestinal symptoms. The patient's speech, language, and mental status examination was normal. Manual muscle strength testing revealed moderately severe, symmetrical weakness in proximal and distal upper and lower extremity muscles. Deep tendon reflexes were brisk in the upper extremities and at the knees, but absent at the ankles bilaterally. Extensor plantar responses were present bilaterally. Sensory examination showed reduced proprioception in the toes, absent vibration sense at the ankles, and impaired light touch distal to the knees. Gait was ataxic with a positive Romberg sign. No appendicular ataxia was noted.
An extensive array of blood tests were performed including a normal complete blood count, normal chemistry, and normal methylmalonic acid levels. Serum copper levels were reduced at 0.51 g/mL (normal 0.75-1.45), and serum zinc was also borderline low at 0.64 g/mL (normal 0.66 -1.10). Gliadin IgA and IgG antibodies were markedly elevated at Ͼ400 EU (0.0 -30) and 63.8 EU (Ͻ20), respectively. Tissue transglutaminase antibodies were also elevated at Ͼ250 U (0.0 -30). Vitamins D, E, and A were all within normal limits; however, serum carotene was reduced at 17 g/dL(48 -200). Serum vitamin B12 level was 1052 ng/L on replacement.
Nerve conduction studies and needle EMG showed evidence of a mild, length-dependent, predominantly axonal sensorimotor peripheral neuropathy. Median and tibial somatosensory-evoked potentials (SEP) were abnormal, showing slowing in central somatosensory pathways in the cervical spinal cord. Magnetic resonance imaging (MRI) scans of the cervical and thoracic spinal cord were normal. Brain MRI showed mild T2 hyperintensities in cerebral white matter, compatible with small vessel ischemic changes. No cerebellar atrophy was identified. Duodenal biopsies obtained from the proximal duodenum showed villous atrophy, crypt hyperplasia, and chronic inflammation with intraepithelial lymphocytosis, confirming the diagnosis of celiac disease. The patient was diagnosed with celiac disease resulting in copper deficiency myeloneuropathy. A gluten-free diet and copper supplementation was initiated, which resulted in normalization of the patient's serum copper levels within 2 weeks.
At the time of the 3-month follow-up examination, the patient reported improvement in her gait, less numbness in her lower extremities, and weight gain. Repeat neurologic examination confirmed clinical improvement, with mild, residual weakness evident in only interossei and iliopsoas muscles, and less severe impairment in light-touch sensation in the lower limbs. Median and tibial SEPs were repeated. The median SEP study normalized, and the tibial SEP was unchanged. Repeat serological testing showed normalization of serum copper levels and marked decrease in gliadin antibodies, with gliadin IgG of 40.0 EU (0.0 -30) and IgA of 57.6 EU (Ͻ20).
DISCUSSION
This case portrays a slowly progressive myeloneuropathy resulting from copper deficiency, caused by occult celiac disease. This patient had typical features of copper deficiency manifesting as a sensory ataxia, with clinical and electrodiagnostic findings revealing a myeloneuropathy. Interestingly, this patient had no obvious gastrointestinal symptoms to suggest celiac disease. However, the weight loss, osteoporosis, and elevated gliadin and tissue transglutaminase antibodies prompted duodenal biopsy, which confirmed the diagnosis. To our knowledge there have been only 2 other reported cases of celiac disease associated with copper deficiency myeloneuropathy. 3, 4 However, the role of celiac disease in the development of copper deficiency was not emphasized in these cases. Copper absorption most likely occurs in the stomach and proximal duodenum. 2 Celiac disease has previously been associated with copper deficiency in patients with anemia but without neurologic symptoms, likely due to malabsorption. 5 Patients with copper deficiency myeloneuropathy typically present with marked lower limb sensory loss and a sensory ataxia, resulting in severe gait unsteadiness. 1, 2 The sensory loss is usually profound and involves all sensory modalities. Deep tendon reflexes may be preserved or even increased at the knees and reduced or absent at the ankles, and extensor plantar responses may be seen. 1 Lower limb weakness is commonly seen, but is typically mild and primarily in distal muscles.
Nerve conduction studies in patients with copper deficiency myeloneuropathy may show a reduction in lower limb compound muscle action potential amplitudes, and reduced or absent sensory nerve action potentials. 1 Median and tibial somatosensory evoked potentials in these patients show slowing in somatosensory pathways in the cervical spinal cord. 1 Cervical spine MRI may show T2 hyperintensity in the posterior columns. 2 Copper supplementation in these patients typically results in stabilization of neurologic signs and symptoms, but may not necessarily result in substantial improvement.
The most commonly recognized neurologic manifestations of celiac disease are ataxia and peripheral neuropathy. 6 The cause of neurologic dysfunction in celiac disease is not known. An immunemediated pathogenesis has been suggested, but has not been established. Vitamin deficiency resulting from malabsorption has been proposed as a possible cause, but has typically not been found. However, we could find no mention of copper levels being checked in previous studies of celiac-associated neurologic disease.
It is interesting to speculate about the role of possible copper deficiency in some celiac patients with neurologic disease. Gait ataxia seems to be particularly common in patients with celiac disease. 6, 7 Although some of these patients have cerebellar signs, abnormal dorsal column function as demonstrated on tibial SEPs 7 and at autopsy, 6 suggest that the gait impairment may result from dorsal column dysfunction, as is the case with copper deficiency. 1 This case highlights the importance of screening for celiac disease as part of the diagnostic evaluation of patients with copper deficiency myeloneuropathy. Celiac disease should be considered even in the absence of gastrointestinal symptoms. Adoption of a gluten-free diet and copper supplementation resulted in prompt normalization of copper deficiency in our patient. Further study of the role of copper deficiency in celiac-associated neurologic dysfunction is warranted.
